Non-alcoholic fatty liver disease: What's in our arsenal?
Lifestyle changes and metabolic syndrome management are the best interventions for NAFLD. Less clear is which agents to use for liver-directed pharmacotherapy.
Department of Family Medicine, Metrohealth Medical Center, Cleveland, OH, USA. Email: jdasarathy@metrohealth.org.
Jaividhya
J
Dasarathy
Department of Hospital Medicine, Cleveland Clinic Foundation, OH, USA.
Sanath
S
Allampati
Department of Family Medicine, Metrohealth Medical Center, Cleveland, OH, USA.
Christine
C
Alexander
Department of Gastroenterology and Hepatology, Cleveland Clinic, OH, USA.
Arthur
A
McCullough
D000328:Adult; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008019:Life Style; D008297:Male; D024821:Metabolic Syndrome / Q000517:prevention & control*; D065626:Non-alcoholic Fatty Liver Disease / Q000175:diagnosis* / Q000188:drug therapy*; D009765:Obesity / Q000517:prevention & control*; D012307:Risk Factors; D016896:Treatment Outcome; D014481:United States
D000960:Hypolipidemic Agents